M&A Deal Summary |
|
|---|---|
| Date | 2011-02-14 |
| Target | Ricerca Biosciences - Efficacy Pharmacology Operating Unit |
| Sector | Life Science |
| Buyer(s) | Numira Biosciences |
| Sellers(s) | Ricerca Biosciences |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2005 |
| Sector | Life Science |
Numira Biosciences, Inc. is a rapidly-growing, specialty contract research organization (CRO) that provides powerful imaging solutions for researchers attempting to answer questions related to the onset and progression of disease, drug efficacy, and drug safety in animal models.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (Washington) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2011) | 1 of 1 |
Ricerca Biosciences LLC is a provider of comprehensive, integrated suite of services to accelerate drug development. Company combine nonclinical support for drug candidate selection with analytical and chemical development expertise to bring drug candidates through all phases of development.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector (Life Science) | 1 of 2 |
| Type (Divestiture) | 1 of 3 |
| State (Washington) | 1 of 1 |
| Country (United States) | 1 of 3 |
| Year (2011) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-09-20 |
Ricerca Biosciences - Pan Labs Pharmacology Unit
United States Pan Labs is a provider in early stage discovery services with a portfolio that provides molecular pharmacology, functional pharmacology, cellular services, and informatics analytics. Pan Labs has built a reputation for maintaining high quality service and customer dependability while delivering the most up-to-date pharmacology assays to match emerging testing needs. |
Sell | - |
